tiprankstipranks
Advertisement
Advertisement
Precigen Earnings Call Signals Powerful Launch Momentum
PremiumCompany AnnouncementsPrecigen Earnings Call Signals Powerful Launch Momentum
24d ago
Precigen jumps on Q1 outlook despite earnings miss
Premium
The Fly
Precigen jumps on Q1 outlook despite earnings miss
24d ago
Buy Rating on Papzimeos Driven by Strong Early Launch Traction, Multi‑Year Growth Catalysts, and Long-Term IP Protection
Premium
Ratings
Buy Rating on Papzimeos Driven by Strong Early Launch Traction, Multi‑Year Growth Catalysts, and Long-Term IP Protection
24d ago
Is PGEN a Buy, Before Earnings?
PremiumPre-EarningsIs PGEN a Buy, Before Earnings?
1M ago
JPMorgan healthcare analysts hold an analyst/industry conference call
Premium
The Fly
JPMorgan healthcare analysts hold an analyst/industry conference call
5M ago
Precigen’s Optimistic Earnings Call Highlights Papcemias Success
Premium
Company Announcements
Precigen’s Optimistic Earnings Call Highlights Papcemias Success
5M ago
Precigen’s Promising Phase 2 Study: PRGN-2009 and Pembrolizumab for Cervical Cancer
PremiumCompany AnnouncementsPrecigen’s Promising Phase 2 Study: PRGN-2009 and Pembrolizumab for Cervical Cancer
6M ago
Precigen presents long-term data demonstrating durable responses to PAPZIMEOS
Premium
The Fly
Precigen presents long-term data demonstrating durable responses to PAPZIMEOS
6M ago
Precigen Converts Preferred Stock to Common Shares
Premium
Company Announcements
Precigen Converts Preferred Stock to Common Shares
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100